Perphenazine and Crestor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Perphenazine (perphenazine) and Crestor (rosuvastatin calcium). Common drug interactions include fall among females and abdominal discomfort among males.

The phase IV clinical study analyzes what interactions people have when they take Perphenazine and Crestor. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Perphenazine?

Perphenazine has active ingredients of perphenazine. It is often used in bipolar i disorder. eHealthMe is studying from 2,712 Perphenazine users. Check the latest studies of Perphenazine.

What is Crestor?

Crestor has active ingredients of rosuvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 149,762 Crestor users. Check the latest studies of Crestor.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 23, 2026

21 people who take Perphenazine and Crestor together, and have interactions are studied.

Perphenazine and Crestor drug interactions.

What are the common drug interactions of Perphenazine and Crestor, by gender? *:

female:

  1. Fall
  2. Pain
  3. Balance disorder
  4. Blood calcium decreased
  5. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  6. Constipation
  7. Creatinine renal clearance decreased
  8. Depressed level of consciousness
  9. Hypotension (abnormally low blood pressure)
  10. Mobility decreased (ability to move is reduced)

male:

  1. Abdominal discomfort
  2. Alopecia (absence of hair from areas of the body)
  3. Dyspnoea (difficult or laboured respiration)
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Injury
  6. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  7. Multiple fractures
  8. Osteoporosis (bones weak and more likely to break)
  9. Pneumonia
  10. Renal disorder (kidney disease)

What are the common drug interactions of Perphenazine and Crestor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)

50-59:

  1. Loss of consciousness
  2. Renal failure acute (rapid kidney dysfunction)
  3. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  4. Abasia (inability to walk)
  5. Bedridden
  6. Decreased appetite
  7. Dysgraphia (impaired ability to learn to write)
  8. Headache (pain in head)
  9. Tobacco user
  10. Vision blurred

60+:

  1. Fall
  2. Balance disorder
  3. Pain
  4. Sedation
  5. Dyspnoea (difficult or laboured respiration)
  6. Drug abuse
  7. Overdose
  8. Creatinine renal clearance increased
  9. Chronic kidney disease
  10. Dysphagia (a condition in which swallowing is difficult or painful)

What are the existing conditions these people have? *

  1. Pain: 6 people, 28.57%
  2. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 5 people, 23.81%
  3. Gastric Ulcer (stomach ulcer): 5 people, 23.81%
  4. Urinary Tract Infection: 4 people, 19.05%
  5. Thyroid Diseases: 4 people, 19.05%
  6. Bladder Disorder: 4 people, 19.05%
  7. Constipation: 4 people, 19.05%
  8. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 4 people, 19.05%
  9. Dementia (madness): 4 people, 19.05%
  10. Fibromyalgia (a long-term condition which causes pain all over the body): 4 people, 19.05%

* Approximation only. Some reports may have incomplete information.

Do you take Perphenazine and Crestor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Perphenazine and Crestor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Perphenazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Crestor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Perphenazine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Crestor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on perphenazine and rosuvastatin calcium (the active ingredients of Perphenazine and Crestor, respectively), and Perphenazine and Crestor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: